Discontinued — last reported Q4 '23
Leidos Holdings Health — Operating Income (Loss) decreased by 3.3% to $147.00M in Q4 2023 compared to the prior quarter. Year-over-year, this metric grew by 70.9%, from $86.00M to $147.00M. Over 2 years (FY 2021 to FY 2023), Health — Operating Income (Loss) shows an upward trend with a 9.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher income indicates improved operational efficiency, better pricing power, or effective cost management within the segment.
Measures the profitability of the Health segment by subtracting operating expenses from segment revenues. It reflects th...
Standard segment reporting metric across all publicly traded companies, comparable to 'Segment Operating Profit'.
ldos_segment_health_operating_income_loss| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $102.00M | $107.00M | $130.00M | $103.00M | $118.00M | $126.00M | $91.00M | $86.00M | $107.00M | $122.00M | $152.00M | $147.00M |
| QoQ Change | — | +4.9% | +21.5% | -20.8% | +14.6% | +6.8% | -27.8% | -5.5% | +24.4% | +14.0% | +24.6% | -3.3% |
| YoY Change | — | — | — | — | +15.7% | +17.8% | -30.0% | -16.5% | -9.3% | -3.2% | +67.0% | +70.9% |